CCRT

PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE IVAPM PAIN MANAGEMENT FORUM IN INDIANAPOLIS, INDIANA

Retrieved on: 
Monday, April 8, 2024

PetVivo intends to exhibit its lead product, SPRYNG™ with OsteoCushion™ Technology.

Key Points: 
  • PetVivo intends to exhibit its lead product, SPRYNG™ with OsteoCushion™ Technology.
  • Spryng is an intra-articular injectable veterinary medical device composed of sterilized, extra-cellular matrix microparticles.
  • Such action promotes the restoration of proper joint mechanics, thereby aiding in the management of noninfectious sources of joint pain such as joint instability, degenerative joint disease and osteoarthritis.
  • For more information about PetVivo Holdings, Inc. please contact [email protected] or visit https://petvivo.com/
    Pain Management Forum Exhibit Details:
    Location: The JW Marriott in Indianapolis, Indiana
    Presentation Title: How do we Elevate Our Strategy for Managing Osteoarthritis in Pets?

Cervical Cancer Studies Outline Innovative Treatment Options For Patients In 2024

Retrieved on: 
Thursday, February 15, 2024

Research highlights the critical link between HPV (human papillomavirus) and cervical cancer, with the virus responsible for the majority of cases.

Key Points: 
  • Research highlights the critical link between HPV (human papillomavirus) and cervical cancer, with the virus responsible for the majority of cases.
  • Regular cervical cancer screening is essential for those aged 21 to 65, incorporating HPV testing followed by further assessments for those with positive results.
  • In evaluating treatment efficacy for stage IB2 to IIB cervical carcinoma, a 12-year study involving 626 patients compared neoadjuvant chemotherapy followed by surgery (NACT-S) with concomitant chemoradiotherapy (CCRT).
  • Cervical Cancer Awareness Month is a crucial time to raise public awareness about cervical cancer and the importance of early detection and treatment.

STELLA & CHEWY'S LAUNCHES NEW DENTAL TREATS PROMOTING CANINE ORAL HEALTH

Retrieved on: 
Wednesday, February 7, 2024

OAK CREEK, Wis., Feb. 7, 2024 /PRNewswire/ -- Stella & Chewy's, the category leader in the raw pet food space, announces the launch of Dental Delights – a fun, engaging treat that's clinically proven to help control plaque and tartar – just in time for National Pet Dental Health Month.

Key Points: 
  • In fact, dental disease is one of the most common medical conditions seen by veterinarians, according to Stella & Chewy's veterinarian partner, Dr. Angie Krause, DVM, CVA, CCRT at Boulder Holistic Health.
  • Dental Delights are specially designed to roll and flip, providing extra stimulation while bringing joy to a dog's dental hygiene.
  • "At Stella & Chewy's, we are always looking for innovative ways to promote pet health, whether it's through food or preventative care.
  • Stella & Chewy's Dental Delights treats come in four sizes, extra-small, small, medium and large, with single-serve treats available in the small, medium and large sizes, making them a great solution for dogs of different sizes.

Others First Inc. Provides 1200 Thanksgiving Meals to Needy Families on November 19, 2022

Retrieved on: 
Wednesday, January 4, 2023

PONTIAC, Mich., Jan. 4, 2023 /PRNewswire/ -- On November 19, 2022, Others First Inc. hosted its ninth annual Thanksgiving Outreach program, giving away 1200 Thanksgiving meals to those in need.

Key Points: 
  • PONTIAC, Mich., Jan. 4, 2023 /PRNewswire/ -- On November 19, 2022, Others First Inc. hosted its ninth annual Thanksgiving Outreach program, giving away 1200 Thanksgiving meals to those in need.
  • turkey, two cans of corn, two cans of green beans, mashed potatoes, stuffing, gravy, cranberry sauce, dinner rolls, and cheesecake.
  • Provide 1200 Thanksgiving Meals to Needy Families on November 19, 2022
    The Thanksgiving meals were distributed to people whose situations were verified by the aid organizations affiliated with Others First.
  • Each of these individuals received a voucher in advance and could exchange them for meals the day of the event.

Global Softgel Capsule Market Report 2022: Increased Number of Clinical Trials Supporting Softgel Capsule Use to Drive Revenue Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, November 15, 2022

The "Global Softgel Capsule Market, By Type, By Application, By Manufacturers & By Region- Forecast and Analysis 2022-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Softgel Capsule Market, By Type, By Application, By Manufacturers & By Region- Forecast and Analysis 2022-2028" report has been added to ResearchAndMarkets.com's offering.
  • Softgel capsules have several advantages, including ease of ingesting, odour and taste masking, improved absorption, higher bioavailability, and superior atmospheric stability.
  • Global Softgel capsule market is segmented based on type, application, manufacturers, and region:
    Based on type, market is segmented into gelatin/animal based, non animal.
  • The increasing number of clinical trials testing the efficacy of soft gelatin capsules in the treatment of various disorders is a significant factor fueling market expansion.

Akeso's Cadonilimab (PD-1/CTLA-4 Bi-specific) included in the 2022 CSCO Guidelines as the Top Recommendation for Cervical Cancer Immunotherapy

Retrieved on: 
Monday, October 17, 2022

HONG KONG, Oct. 16, 2022 /PRNewswire/ -- Chinese Society of Clinical Oncology (CSCO), an authoritative Chinese oncology institution, recently published the 2022 CSCO Guidelines on Diagnosis and Treatment of Cervical Cancer.

Key Points: 
  • HONG KONG, Oct. 16, 2022 /PRNewswire/ -- Chinese Society of Clinical Oncology (CSCO), an authoritative Chinese oncology institution, recently published the 2022 CSCO Guidelines on Diagnosis and Treatment of Cervical Cancer.
  • Akeo's (Cadonilimab injection), a first-in-class PD-1/CTLA-4 bi-specific antibody independently developed by the Company, was included in the guidelines as the top recommended second-line immunotherapy for recurrent or metastatic cervical cancer (R/M CC).
  • As the globally first approved dual immune checkpoint bi-specific antibody, Cadonilimab is the first approved immuno-oncology drug for advanced cervical cancer treatment in China.
  • In addition, a registrational/phase III trial of Cadonilimab plus concurrent chemoradiotherapy (CCRT) for locally advanced cervical cancer (LACC) is also ongoing.

Lieff Cabraser Announces That Judge Grants Final Approval to Settlement Aimed at Implementing Landmark Reforms in University of Michigan Campus Sexual Abuse Class Action

Retrieved on: 
Thursday, August 4, 2022

On August 3, 2022, U.S. District Judge Victoria A. Roberts issued an Order granting final approval to the settlement of the class action lawsuit against the University of Michigan arising out of UofM campus sexual misconduct.

Key Points: 
  • On August 3, 2022, U.S. District Judge Victoria A. Roberts issued an Order granting final approval to the settlement of the class action lawsuit against the University of Michigan arising out of UofM campus sexual misconduct.
  • In comments from the bench, Judge Roberts called the settlement an outstanding outcome that she hopes is emulated around the country.
  • We are proud of this Settlement, notes Lieff Cabraser senior partner Jonathan D. Selbin, who represents the plaintiffs in the case.
  • The decades of abuse by Dr. Anderson are a dark stain on the history of the University of Michigan.

Increasing natural disaster preparedness of small island developing states through citizenship by investment programmes: CS Global Partners

Retrieved on: 
Friday, July 8, 2022

Inward investment injections from CBI programmes are a necessity for small island countries like Dominica, St Kitts and Nevis and St Lucia as they aid natural disaster preparedness.

Key Points: 
  • Inward investment injections from CBI programmes are a necessity for small island countries like Dominica, St Kitts and Nevis and St Lucia as they aid natural disaster preparedness.
  • On average, natural disasters cause damage equivalent to 2.1% of GDP every year in SIDS.
  • According to the Emergency Events Database (EM-DAT), the economic impact of a natural disaster is calculated on a per-capita basis.
  • In conclusion, the macroeconomic impact of citizenship by investment programmes is significant, especially in the areas of natural disaster management and economic development.

NANOBIOTIX: New Data Featuring NBTXR3 Plus Chemoradiation and in the Preoperative Setting Support Broad Applicability for Head and Neck Cancer and Other Solid Tumor Indications

Retrieved on: 
Sunday, June 5, 2022

Most cisplatin-eligible patients with LA-HNSCC receive multimodal therapy including high dose concurrent chemoradiation (CCRT) as the standard of care.

Key Points: 
  • Most cisplatin-eligible patients with LA-HNSCC receive multimodal therapy including high dose concurrent chemoradiation (CCRT) as the standard of care.
  • While CCRT has shown to improve local control and extend survival, the toxicity of high dose cisplatin creates challenges.
  • These patients received a single intratumoral injection of NBTXR3, followed by a low-dose weekly regimen of CCRT.
  • Of these evaluable patients, 3, 6, and 3 patients received NBTXR3 at the 5%, 10%, and 15% dose levels, respectively.

Lieff Cabraser & Co-Counsel Announce That Students Reach Agreement With University of Michigan to Implement Landmark Reforms Addressing On-Campus Sexual Misconduct

Retrieved on: 
Thursday, March 24, 2022

CCRTs are widely recognized by experts on sexual misconduct prevention as an indispensable tool to achieve comprehensive prevention of campus sexual violence.

Key Points: 
  • CCRTs are widely recognized by experts on sexual misconduct prevention as an indispensable tool to achieve comprehensive prevention of campus sexual violence.
  • They have been adopted by colleges and universities throughout the country, including the University of South Florida and the University of California.
  • The plaintiffs are represented by Lieff Cabraser Heimann & Bernstein, LLP, the Miller Law Firm, P.C., and Sauder Schelkopf LLC.
  • We believe that these reforms will undoubtedly improve campus life for the next generation of students, said Joe Sauder of Sauder Schelkopf LLC.